Compare ADMA Biologics Inc (ADMA) vs Goodyear Tire & Rubber Co (GT) Price & Performance

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

Goodyear Tire & Rubber (GT) trades at $7.02, up 6.53% today, with a bullish technical signal from moving averages and oscillators. The stock shows deep value metrics with P/E of 4.69 and P/B of 0.66, but faces profitability challenges with negative net income margin of -11.64% and ROE of -52.56%. Recent developments include the company's move to the S&P SmallCap 600 and new NASA lunar tire contract, while Q1 2026 earnings beat estimates despite a net loss.

The outlook remains mixed with analyst consensus at Buy (34.62%) and price target of $8.80 offering 25% upside, but persistent operational headwinds and declining revenue trends pose significant risks. Investment opportunity lies in valuation discount and Goodyear Forward program benefits, though weak tire volumes and negative cash flow projections for 2026 require careful monitoring.